✦ LIBER ✦

Aprotinin: Effective, but risky?

✍ Scribed by James D. Perkins

Book ID: 102465242
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 81 KB
Volume: 12
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20866

No coin nor oath required. For personal study only.

✦ Synopsis

Background: The majority of patients undergoing surgical treatment for ST-elevation myocardial infarction receive antifibrinolytic therapy to limit blood loss. This approach appears counterintuitive to the accepted medical treatment of the same conditionnamely, fibrinolysis to limit thrombosis. Despite this concern, no independent, large-scale safety assessment has been undertaken. Methods: In this observa-

📜 SIMILAR VOLUMES

Idraparinux effective, but risky, for ve

Idraparinux effective, but risky, for venous thromboembolism

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Biocontrol—risky but necessary?

✍ M.B Thomas; A.J Willis 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Fighting as a subordinate in finch flock

Fighting as a subordinate in finch flocks: escalation is effective but risky

✍ J.C. Senar; M. Camerino; N.B. Metcalfe 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Regeneration: Rewarding, but potentially

Regeneration: Rewarding, but potentially risky

✍ Bernhard Egger 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

Clinical trials risky but necessary

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Geothermal energy promising but risky

📂 Article 📅 1976 🏛 American Chemical Society 🌐 English ⚖ 320 KB